Word

NDC

Status

Dead

Status Code

606

Status Date

Monday, July 1, 2019

Serial Number

86613157

Mark Type

4000

Filing Date

Tuesday, April 28, 2015

Published for Opposition

Tuesday, April 5, 2016

Abandoned Date

Monday, July 1, 2019

Trademark Owner History

Memorial Sloan Kettering Cancer Center - Owner At Publication

Classifications

5 Pharmaceutical preparations and substances for diagnosis and targeted treatment of cancer and tumor diseases; pharmaceutical preparations and substances for diagnosis and treatment of viral, bacterial, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, inflammatory, dermatological, psychiatric and immune system related diseases and disorders; therapeutic agents for diagnosis and targeted treatment of cancer and tumor diseases; therapeutic agents for diagnosis and treatment of viral, bacterial, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, inflammatory, dermatological, psychiatric and immune system related diseases and disorders; therapeutic pharmaceuticals and substances for the diagnosis and treatment of viral, bacterial, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, inflammatory, dermatological, psychiatric and immune system related diseases and disorders; pharmaceutical preparations and substances for diagnosis and treatment of diseases and disorders; therapeutic agents for diagnosis and treatment of diseases and disorders

42 Research and development in the fields of pharmaceuticals, biotechnology, therapeutics, and drug formulation and delivery; research and development in the field of targeted therapies for cancer and tumor diseases; research and development in the field of targeted therapies for viral, bacterial, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, inflammatory, dermatological, psychiatric and immune system related diseases and disorders; consulting services in the field of scientific research; consulting services in the field of research and development for pharmaceuticals, biotechnology, therapeutics, and drug formulation and delivery; consulting services in the field of clinical trials; testing, inspection, research, or development of pharmaceutical and therapeutic preparations; pharmaceutical and therapeutic drug development services; pharmaceutical and therapeutic product evaluation; conducting early evaluations in the field of new pharmaceuticals and therapeutics; conducting quality control testing, feasibility testing, toxicology testing and pharmacology testing for pharmaceuticals and therapeutics; laboratory research services relating to pharmaceuticals and therapeutics; medical and scientific research, namely, conducting clinical trials for others; product safety testing for pharmaceuticals and therapeutics

Trademark Events

Jul 1, 2019

Abandonment Notice E-Mailed - No Use Statement Filed

Jul 1, 2019

Abandonment - No Use Statement Filed

Nov 30, 2018

Notice Of Approval Of Extension Request E-Mailed

Nov 29, 2018

Extension 5 Granted

Nov 19, 2018

Extension 5 Filed

Nov 29, 2018

Case Assigned To Intent To Use Paralegal

Nov 19, 2018

Teas Extension Received

May 15, 2018

Notice Of Approval Of Extension Request E-Mailed

May 11, 2018

Extension 4 Granted

May 11, 2018

Extension 4 Filed

May 11, 2018

Teas Extension Received

Oct 27, 2017

Notice Of Approval Of Extension Request E-Mailed

Oct 25, 2017

Extension 3 Granted

Oct 25, 2017

Extension 3 Filed

Oct 25, 2017

Teas Extension Received

May 12, 2017

Notice Of Approval Of Extension Request E-Mailed

May 10, 2017

Extension 2 Granted

May 10, 2017

Extension 2 Filed

May 10, 2017

Teas Extension Received

Nov 8, 2016

Notice Of Approval Of Extension Request E-Mailed

Nov 4, 2016

Extension 1 Granted

Nov 4, 2016

Extension 1 Filed

Nov 4, 2016

Teas Extension Received

May 31, 2016

Noa E-Mailed - Sou Required From Applicant

Apr 5, 2016

Official Gazette Publication Confirmation E-Mailed

Apr 5, 2016

Published For Opposition

Mar 16, 2016

Notification Of Notice Of Publication E-Mailed

Mar 2, 2016

Law Office Publication Review Completed

Feb 25, 2016

Approved For Pub - Principal Register

Feb 25, 2016

Teas/Email Correspondence Entered

Feb 25, 2016

Correspondence Received In Law Office

Feb 18, 2016

Assigned To Lie

Feb 11, 2016

Teas Response To Office Action Received

Aug 12, 2015

Notification Of Non-Final Action E-Mailed

Aug 12, 2015

Non-Final Action E-Mailed

Aug 12, 2015

Non-Final Action Written

Aug 6, 2015

Assigned To Examiner

May 9, 2015

New Application Office Supplied Data Entered In Tram

May 1, 2015

New Application Entered In Tram